We propose that individuals with high DARC expression levels may be protected from the protumoral impact of immunosenescence and inflamm-aging, and in contrast, individuals with low DARC levels are at greater risk for immunosenescence, inflamm-aging, and cancer development. This evidence concerns the gene ACKR1 and cancer.